Ledger.Open graph →
SEC Form D · Amendment · filed May 30, 2017

Eureka Therapeutics Inc

Offering
$60.0M
Sold
$26.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Emeryville, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Sandy Chau · Santa Clara, CADirectorCheng Liu · Hong Kong, IsraelExec · DirectorHsing Kung · Santa Clara, CADirectorQiushi Fu · Beijing, IsraelDirectorMichael Cannon · San Diego, CADirectorChih-Kai Cheng · Taipei, F5DirectorSandy Chau · Emeryville, CADirectorCheng Liu · Emeryville, CAExec · DirectorHsing Kung · Emeryville, CADirectorQiushi Fu · Emeryville, CADirectorMichael Cannon · San Diego, CADirectorChih-Kai Cheng · Santa Clara, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗